Hansa Biopharma AB (publ)
Hansa Biopharma AB (publ) (HNSBF) Revenue
Annual & quarterly revenue history · segment & region breakdown
HNSBF · revenue · updated Jun 10, 2026
Core revenue metrics
Trailing 12 monthsHansa Biopharma AB (publ) trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Hansa Biopharma AB (publ) receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Hansa Biopharma AB (publ) reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Hansa Biopharma AB (publ)'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
HNSBF revenue · 4 questionsHNSBF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Hansa Biopharma AB (publ) SEC filings · GAAP · Hansa Biopharma AB (publ) SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026